A gene borrowed from the naked mole rat, an animal famous for extraordinary longevity and disease resistance, helped mice live a little longer and stay healthier, pointing to a surprising biological ...
Biology textbooks explain that cells follow a universal rule when processing gene transcripts to make proteins. Non-coding snippets of RNA are bracketed by a guanine-thymine (GT) nucleotide sequence ...
TUCSON, Ariz. — Investigators looking to track down Nancy Guthrie’s suspected kidnappers are turning to a relatively new technology that has been attributed to solving some of the most prolific ...
ST. PETERSBURG, Fla. - Investigative genetic genealogy, which is a relatively new forensic tool, is now being considered in the search for answers in the Nancy Guthrie case. Big picture view ...
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments ...
A cell-specific gene therapy may provide relief from chronic pain, a study in mice shows. Chronic pain is one of the most common reasons that adults seek medical care. In 2023, nearly a quarter of ...
Antibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing ...
DNA can be thought of as a vast library that stores all genetic information. Cells do not use this information all at once. Instead, they copy only the necessary parts into RNA, which is then used to ...
Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike ...
Deepwater's Gene Munster joins 'Fast Money' to talk Intel quarterly results. People in Denmark 'stunned' by Trump's Greenland comments, former ambassador says Texas leads the nation in supplying new ...
ROCHESTER — Vyriad, a growing Rochester firm, recently raised an additional $25 million in funding to fuel its “race” to bring a new technology to market that accurately targets cancer within a ...
Lexeo Therapeutics is teaming up with Big Pharma Johnson & Johnson's unit Abiomed to tap its Impella heart pump technology in search of a potentially safer and more effective route for cardiac genetic ...